
Cellebrite DI Ltd.
CLBT
Updated: 24/09/2026, 16:06:16
Cellebrite DI Ltd. delivers specialized digital intelligence solutions crafted for legally authorized investigations. Their comprehensive DI platform enables users to efficiently gather, scrutinize, interpret, and oversee digital information throughout the investigative process. These essential tools are utilized in a wide array of scenarios, including cases involving child exploitation, homicides, counter-terrorism operations, border control, sexual offenses, human trafficking, corporate security incidents, intellectual property theft, and civil litigation. A key offering, the Universal Forensic Extraction Device (UFED), is engineered to surmount significant hurdles in accessing digital evidence, such as intricate device locks, encryption barriers, deleted data, and obscure content that might otherwise conceal crucial information. The company also provides Seeker, designed for analyzing video footage; OSINT Analyze, a real-time deep-dive tool for examining open-source information across the surface, deep, and dark web; and Crypto Tracer, which deciphers blockchain transactions alongside related data from numerous sources to identify and categorize digital wallets and activities. Cellebrite's clientele includes federal, state, and local government bodies, as well as various enterprise companies and service providers. Established in 1999 and headquartered in Petah Tikva, Israel, the firm operates internationally with a footprint in countries such as the United States, Germany, Singapore, Australia, Brazil, the United Kingdom, France, Canada, Japan, and India. Additionally, Cellebrite Mobile Synchronization Ltd. functions as a subsidiary of Sun Corporation.
No summaries found.
- Share price
- $11.39
- Market cap
- $2.85B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Shiv Ramji
- Employees
- 1,285
- IPO date
- 06/11/2020
- Beta
- 1.146
- Last dividend
- $0.00
- Day range
- $11.36 – $11.55
- 52-week range
- $9.58 – $19.98
- 1-day performance
- -0.96%
- 1-year performance
- 18.89%
- Current drawdown (1Y)
- -42.99%
- CIK
- 0001854587
- CUSIP
- M2197Q107
- ISIN
- IL0011794802
- Created
- 07/12/2025, 03:20:25
- Last update
- 24/09/2026, 16:06:16
Track Cellebrite DI Ltd. with an AI analyst
See which prediction-market events move CLBT, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Cellebrite DI Ltd. (CLBT) Discusses AI Technology and Innovation in Tech Talk Transcript
Seeking Alpha • STOCK • 10/06/2026, 15:02:15
Cellebrite Launches the New Age of Investigations with Genesis, Now Generally Available
PRNewsWire • STOCK • 10/06/2026, 10:30:00
Cellebrite DI Eyes AI, Cloud and FedRAMP as Digital Investigations Demand Grows
MarketBeat • STOCK • 28/05/2026, 05:04:27
Cellebrite DI Sees Federal Rebound as AI, Defense Tools Fuel New Growth
MarketBeat • STOCK • 19/05/2026, 01:04:37
Cellebrite DI Ltd. (CLBT) Presents at J.P.
Seeking Alpha • STOCK • 18/05/2026, 19:10:46
Cellebrite: Positive Q1 Results, But There Is Room For Margin Improvements
Seeking Alpha • STOCK • 16/05/2026, 10:45:09
Cellebrite DI Ltd. (NASDAQ:CLBT) Shows Strong Q1 Growth Despite Analyst Price Target Adjustment
Market Data • Market Data • 15/05/2026, 17:19:36
Cellebrite DI Q1 Earnings Call Highlights
MarketBeat • STOCK • 14/05/2026, 12:09:32
Cellebrite DI Ltd. (CLBT) Q1 Earnings and Revenues Top Estimates
Zacks Investment Research • STOCK • 14/05/2026, 11:21:15
Cellebrite: A Rare SaaS Play Where AI Is A Tailwind, Not A Threat
Seeking Alpha • STOCK • 06/04/2026, 17:19:34
Cellebrite Changes the Investigative Game with the Launch of Genesis, the Groundbreaking Agentic AI Solution for Making Our World Safer
PRNewsWire • STOCK • 16/03/2026, 09:30:00
Cellebrite DI Ltd. (CLBT) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript
Seeking Alpha • STOCK • 03/03/2026, 14:02:14